A citation-based method for searching scientific literature

Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
Times Cited: 130



Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles, Gabriella Pichert, Laura Van t'veer, Nadine Tung, Jeffrey N Weitzel, Fergus J Couch, Wendy S Rubinstein, Patricia A Ganz, Mary B Daly, Olufunmilayo I Olopade, Gail Tomlinson, Joellen Schildkraut, Joanne L Blum, Timothy R Rebbeck. JAMA 2010
Times Cited: 836




List of shared articles



Times cited

Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
Lenika M De Simone, Aishwarya Arjunan, Kristen J Vogel Postula, Tara Maga, Leslie A Bucheit. J Genet Couns 2021
1

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
10


Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.
Siddhartha Yadav, Fergus J Couch. Am Soc Clin Oncol Educ Book 2019
17


Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress.
A van Erkelens, A S Sie, P Manders, A Visser, L E Duijm, R M Mann, M Ten Voorde, H Kroeze, J B Prins, N Hoogerbrugge. Eur J Cancer 2017
9

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
25

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, Debra L Richardson. Gynecol Oncol 2015
159


Proposed shift in screening for breast cancer--reply.
Mary-Claire King, Amnon Lahad, Ephrat Levy-Lahad. JAMA 2015
3

Genetic tests to identify risk for breast cancer.
Julie A Lynch, Vickie Venne, Brygida Berse. Semin Oncol Nurs 2015
17

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
202


Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Thomas Paul Slavin, Mariana Niell-Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R Blazer, Jeffrey N Weitzel. Front Oncol 2015
68

Evaluation of a heredofamilial cancer unit in increasing family history collection and genetic counseling referrals among Spanish oncologists at a university hospital.
Iván Márquez-Rodas, Sara López-Tarruella, Yolanda Jerez, Mercedes Cavanagh, Sara Custodio, Daniel López-Trabada, Beatriz Moya, Sara Pérez, Ana B Rupérez, Miguel Martín. J Genet Couns 2014
3

Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.
Jacquelyn Powers, Jill Elise Stopfer. J Obstet Gynecol Neonatal Nurs 2014
2

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
174

Precision medicine meets public health: population screening for BRCA1 and BRCA2.
Ephrat Levy-Lahad, Amnon Lahad, Mary-Claire King. J Natl Cancer Inst 2014
38

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
101

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
187

Family history record and hereditary cancer risk perception according to National Cancer Institute criteria in a Spanish medical oncology service: a retrospective study.
Iván Márquez-Rodas, Daniel López-Trabada, Ana Belén Rupérez Blanco, Sara Custodio Cabello, María Isabel Peligros Gómez, María Orera Clemente, Felipe A Calvo, Miguel Martín. Oncology 2012
5


Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
Brian S Finkelman, Wendy S Rubinstein, Sue Friedman, Tara M Friebel, Shera Dubitsky, Niecee Singer Schonberger, Rochelle Shoretz, Christian F Singer, Joanne L Blum, Nadine Tung,[...]. J Clin Oncol 2012
24



Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
Jennifer J Johnston, Wendy S Rubinstein, Flavia M Facio, David Ng, Larry N Singh, Jamie K Teer, James C Mullikin, Leslie G Biesecker. Am J Hum Genet 2012
159

An overview of hereditary breast and ovarian cancer syndrome.
Edith Caroline Smith. J Midwifery Womens Health 2012
7


Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
146